Skip to content

← All developments

FDA Recalls · August 25, 2026 · Primary source

Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate Matter

Score 43PRIMARYregulatoryFDA

Summary

Baxter International issued a voluntary nationwide recall of one lot of 70% Dextrose Injection due to the potential presence of stainless steel particulate matter identified in the solution. The recall was announced August 25, 2026, and covers a single production lot distributed nationally. No patient injury is referenced in the excerpt.

What this may mean

Hospitals, SNFs, home health agencies, and other settings that administer 70% Dextrose Injection must identify and quarantine the recalled lot from inventory. The recall does not affect other Baxter lots or dextrose products not covered by the notice. FDA product-recall compliance obligations apply to facilities in possession of the affected lot.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items